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Direct antigen presentation of tumor-associated antigens 
by tumor cells to T lytnphocytes may induce clonal 
anergy as a mechanism of escape from. inunune surveil-
lance. B7-1 is a costimulatory molecule for the activation 
of both CD4 + and CDS+ T lymphocytes that prevents 
the induction of clonal anergy. Thus, the transfer of 
B7-1 genes into tumor cells can induce protective 
in1munity and lead to tmnor rejection of sotne tmnors 
in model systems of in llillo tmnor growth; however, there 
is no information on whether stable expression of B7- 1 
can affect the in llillo growth of squamous cell carcinotna, 
a conunon skin cancer. Here, we study how the stable 
cell surface expression of high levels ofB7-1 by Pam 212, 
a murine squan1ous cell carcinoma, affects twnor cell-
lymphocyte interactions (lymphocyte proliferation and 
cytotoxicity). Consistent with its costimulatory role, we 
demonstrate that B7-1 can efficiently induce dendritic 
epidermal T-cell proliferation in three different dendritic 
epidermal T-cell cell lines . In addition, B7-1 enhances 
T he B7-1 moJecuJ e (COSO) expressed by ancigen-pre-senting cells ca n provide a costim.ulatory signal for th e activation of both T-cell receptor (TCR)-a./ ~- and TCR-y/8-bea ring T .l ymph ocytes (Turka et a/, 1992; Damle ct a/, 1992; Sperlin g et a/, 1993) . T ransfer ofB7-1 
genes in to tumor cel.ls ca n indu ce protective immunity and lead to 
tum.or rej ection in ce rtain tum or model systems (Chen et a/, 1992; 
Baskar et al, 1993a; Townsend and Allison, 1993), whi ch is dependent 
upon the immun ogeni city of tumors (Chen eta/, 1994) . T he expression 
of B7-1 in immun ogeni c tumors enhances host immu ni ty and induces 
the rej ection of some tumors. T he phenotype of immun e cel.ls 
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dendritic epidermal T-cell cytolytic activity against Pam 
212 cells in an in vitro 51Cr-release assay, which was 
blocked by CTLA- 4/Ig fusion protein. In contrast to 
dendritic epidermal T cells, the expression of B7-1 does 
not alter Pam 212 interactions with either cytotoxic 
T- lymphocytes, natural killer, or lymphokine-activated 
killer cells . B7- 1 expression by Pam 212 cells did not 
alter its ability to grow tumors in rJi r10, as their rate of 
tun1.or growth was the same as vector-transfected Patn 
212 cells, which were B7-1 negative. Our studies indicate 
that B7-1 gene transfer into Pam 212 does not alter its 
tmnorigenicity, because it does not alter tun1or cell-
lymphocyte interactions with cytotoxic T lymphocytes, 
natural killer cells, and lymphokine-activated killer cells . 
Further studies ofB7-1 modified Pam 212 and dendritic 
epidermal T cells will clarify whether T- cell receptor-y/ 
0-bearing T lymphocytes can play a role in immuno-
therapy of Pam 212 squamous cell carcinoma. Key words: 
costimulationlimm.utwthempy I skin ca·ncer. J Itwest Dermatol 
109:728-733, 1997 
responsible for tumor rej ection mediated by B7- 1 has been shown to 
be CDS+ or CD4 + T cells (Chen et a/, 1992; Townsend and Allison, 
1993 ; Baskar er. a/, 1993b). R ecently, one study reported that the 
express ion of B7-1 on EL-4 lymphoma, an immunogenic tumor, 
remits in tumor rejection in allogeneic athymi c nude mice, which w as 
dominantly mediated by T CR-y/ 8-bearing T ce l.ls (Li el al, J 995). 
T here is no information on whether the expression of B7- 1 by 
squamous cell carcinoma will prevent tum or growth in vivo . Pan'l 212 
cells are derived from murin e kera tinocytes (KC) and are nonim.muno-
genic in syngeneic hosts (Yuspa et a/, 1980; C hen e/ a/, 1993) . Although 
th e expression of class l major histocompatibility complex (MHC) 
molecules in Pam 212 is low, it is inducible by inte[feron (IPN)-'Y, 
and Pam 212 ce.lls are rejected by allogeneic (Chen et a/, 1993) as well 
as minor histocompatibility disparate hosts (Chen eta /, 1995) . These 
data indicate that class I MHC and rninor histocompatibility an tigens 
expressed by Pam 212 are adequate to indu ce immune responses in an 
MHC or minor histocompatibility antigen disparate host. In this report, 
we stably transfected B7-1 into Pam 21 2 tumor cells and examined 
how B7-1 expression co uld affect anti-tumor immunity. Although 
B7-l expression by Pam 21.2 played an important role in amplifYing 
dendritic epidermal T-cell (DETC) interactions (proliferation and 
cytotm..icity in response to Pam 212-associated antigens), it did not 
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Figure 1. The pKmB7C~ construct. T he pKmB7C~ construct was generated 
by incorporating the full-l ength B7- 1 eDNA into a pGEM3Z vector containing 
the Kl4 promoter (generous.ly provided by Dr. E. Fuchs), ;md the terminal 
two untranslated exons of the c~ gene. 
alter th eir lysis by cytolytic T lymphocytes (CTL), natura.! killer cells, 
or lymp hokine-activated killer (LAK) effector cells and thus did not 
affect in vivo tumor growth . Pam 212 expression of antigens recognized 
exclusively by DETC, but not by mature eflector cells, is likely to be 
the m echanism responsible for Pant 212's apparent res istance to the 
major effector cells (CTL, natural killer ce Ll s, and LAK cells) of the 
tumor surveillance network. It is likely that B7- 1 gene transfer into 
Pant 212 did not protect against th e i11 IJiuo tumor growth because 
these tumor cells do not direc tly present tumor-associated antigens to 
CTL (i.e. , occupy the TCR for CTL activation). For natural killer 
and LAK cells, Pam 212 may not express the recognition liga nds to 
trigger cytotoxicity by th ese effector cells. 
MATERIAL AND METHODS 
Animals BALB/ CByj fe male mice were obtained ft·om T he jackson Labora-
tory (Ba r H arbor, ME). Mice were 8-12 wk old at the time of use. 
Isolation of n1ouse B7-1 eDNA using reverse transcriptase polymerase 
chain reaction (RT-PCR) Mouse 137- 1 gene was cloned from lipopoly-
saccharide-stimulated C3I--I / Hej spleen cells using R.T- PCR. as described pre-
viously (Nasi r et a/, 1994). BrieRy, total ceLlul ar R.NA was extracted using 
guan idinium isothiocyanate lysing buffer with subsequent CsCI gradient ultra 
centrifugation. O ne n'li crogram of this RNA was reverse tra nscribed with 
random primers (eDNA cycle kit, Invitrogen, San D iego, C A), as suggested by 
the manu £:1cturer. The resulting eDNA was then subjec ted to the polymerase 
chain reac tion (PCR., Perkin-Elmer/Cetus PCR. apparatus, Norwalk, CT ). 
PCR. was perfonned using Tag polymerase (Boehringer, Indianapolis, IN) and 
a pair of primers with the foLlowing syntheti c oligonucleotide sequence: 
Forward primer: 5 ' -TCTCCAAAGCATCTGAAGCTATGGCTTGCAAT, 
Rese rve primer: 5' -GTGCTGAAAGAAAGATTGTACCTCA.TGAGC. 
The 5' oligonucleotide primer corresponds to nucleorides 229-260 of 
published mo use B7-l eDNA sequence and the 3' primer corresponds to 
nucleotides 1236- 1207 (Freeman et a/, 199:1). These oligonucleotides fully 
encompass the open reading frame (n ucleotides 249-11 66) . Denaturation, 
annealing, and extension reactions were ca rri ed out at 94°C fo r 15 s, 56°C fo r 
15 s, and 72°C for 30 s, respec tively, fo r 30 cycles . T hree products of the PCR 
reaction were identifi ed: 1.0 kb , 0.9 kb , and 0.6 kb. T he identity of the longest 
product was confirmed by restriction mapping and sequencing to be that of 
the published B7- 1 eDNA containing the entire open reading frame. T his PCR 
product was cloned directly into the pCI<JI TA clon ing vector (Invitrogen). 
Expression vector construct We used a K 14 promoter (generously provided 
by Dr. E. Fuchs, University of C hicago) incorpora ted into pGEM3Z vector 
(Promega, Madison , W I) with modificatio ns to include splice dono r and 
acceptor sites . T he K14 poly A region was excised by digesting with Bam !--11 
and Hind 1.11. The third and fo urth exons of the C~ gene (Gasco igne et a/, 
1984), which include a 3' untranslated region and polyadenylation signals, were 
incorporated into the K14 poly A defi cient cassette at the BamHl/ Hind Ill 
·sites (Nasir et a/, 1994). T he 1.0-kb mouse B7-1 eDNA was then cloned i;1to 
the BamB I site of the hybrid vector to yield pKml37C~ (Fig 1). 
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Figure 2. Pam 212/ B7-1 transfected clones express high cell surface 
B7-1. Flow cytomeny profiles of B7 expression by the Pam 2 12 transfected 
clones used in these studies . As described in t\llaterial and Methods, Pam 212 
vector-transfected clone (a) or Pam 212/ B7-1 transfected clone (b) were stained 
witb either control human lgG ( ... ) or CTLA-4/ Ig fusion protein (--). 
DNA-n1ediated gene transfection Using a liposome-rned iated technique 
(R ose et a/, 199 '1 ), we co-transfected p H-~-Apr-1-neo em pry vector construct 
(generously provided by Dr. Laurence Kedes) and pKml37C~ into the parental 
Pam 212 cells (Pam 212 wt) to yield 87-1-expressing Pam 2'12 cells (Pam 212/ 
137- 1). The parental Pam 212 cells we re transfected with pH-~-Apr-1 - n eo 
empry construct alone to yie.ld control vector-expressing Pam 212 (Pam 212/ 
V). We also urilized the same pl-l - ~-Apr- 1-neo empry vector construct or pH -
~-Apr-1-neo 137-1 for transfecrion of Line 1, resul ti ng in vector transfected 
Line 1 or B7-l tra nsfec ted Line 'I (Yeh et a/, 1995). These transfectanrs were 
selected in a G418 containing medium (1 00 ~l g per m1) to enri ch stably 
transfected cell lines. After G418 selection, the ce lls were then cloned by 
limiting dilution. All clones that were studied were re- isolated after a second 
limiting dilution. 
Tissue culture tnedia and cell lines Tissue culture medium was H .. PMI 
1640 (JRH Biosc iences, Lenexa, KS) supplemented with 'I 0% fetal bovine 
serum (1-lyclone, Logan, UT), antibiotics (100 U. Penici ll in G, 100 pg 
Streptomycin per rn1 and 0.25 pg Fungizone per ml, Gibco, Grand Island, 
NY), and L-glutamine (Sigma, St. Louis, MO). The parental Pam 212 cell line 
was kindly provided by Dr. Stuart H . Yuspa (Laboratory of Experimental 
Pathology, National Institutes of Health , Bethesda, MD) an d maimai ned in 
monolayer cultme as described previously (Yuspa et a/, 1980; C hen ci a/, 1995). 
Pam 212 does no t express detectable 137- 1 (Fig 2). A.ll Pam 212 rransfectants 
and other cell lines, including EMT6/ R o (BALB/ C mammary sarcoma) , EL-
4 th ymoma (Kubota and Katoh, 1990) , and YAC-J, a class I MH antigen-
defi cient lymphoma of A./ Sn origin (Ki essling et: a/, 1975), were maintained 
in 11i tro similar to tl1 e parental Pam 212 cells. Vector transfected Line 1 and and 
B7-1 transfected Line 1 we re cultured as previously described (Yeh eta/, 1995) . 
All cell lines were free of mycoplasma and viral infections (Chen ct a/. 1995). 
DETC lines Line A3 was derived fi·om BALB/ C athymic nude mice, and 
7-17 derived fi-o m AKR n'lice were characterized as previously described 
(Ku ziel et: t1 /, 1987). C3 was derived from C3 H/ H eJ mice using prcvious.ly 
pubLished protocols (Caughman et a/, 1986; Gaspari eta/, 1993). All tlu·ee cell 
lines expressed y/ o T CR. and CD28. T hese cells were maintained in 11i11·o 
without irradiated syngeneic feeder cells. The culture medium conta ined RPM I 
1640 plus :10% feta l bovine serum , L-glutamine, and antibioti cs, w hich were 
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supplemented with rat sp lenocyte I 0% conca na va lin A (Con A) -conditioned 
supernatant. Ce lls were passaged 2-3 times per week with fresh culture medium . 
Preparation of mouse Langerhans cells Lange rhans cells were prepared 
as described prev iously (Mohamadzadeh er " ' · 1996), wi th the foll owing 
modifi ca tions. B1ieAy. skins of nonnal BALB/C mice we re removed and 
subcutaneous ta t was cleaned foll owed by Aoa ting 011 0.5% trypsin (U.S. 
Biochemica ls, C leve land, O H) at 37°C for L h. T he epidermis was li fted from 
skins and Aoa ted on 0.05')1, DNAse (Sigma) :1t room temperature for 10 min. 
Enzyme reac ti ons we re sto pped by additi on of se rum and buffer, and epidermal 
cells were rdeased by pushing thro ugh a syrin ge and a nylon fil ter. The 
epidennal cells were washed and plated at 2 X 101' cells per ml in R.PMl 
medium supplemented with 10% feta l calf serum . After 2 d incubation, the 
nonadherent cells we re coll ected to enri ch fo r cultured Langerhans cells by 
Ficoii - H.ypagu e gradient cemri fugation (S imon et a/, 199 1; Vedel et a/, 1992) . 
This procedure usually yields about 30% cultmed Langerhans cells. 
Immunostaining, flow cytometric ana lysis, and sterile cell sorting The 
staining procedu re fo r detecting B7-'l cell surf.1ce expression was desc1ibed 
before (Yeh et a/, 1995) . Cells we re detached from the culture dish using 0.1% 
eth ylenediamine te traace tic acid , was hed, and coumed by trypan blue exclusion. 
CTLA-4/ Ig that binds to ce lls that express either B7- 1 or B7- 2, was used to 
detect ce ll surf.1ce expression of B7- l by Pam 2 '12 transfectants. Cells were 
incubated with I 00 J..LI CTLA-4/ Ig (1 0 J..Lg per ml, generously provided by Dr. 
Peter Linsley, Bristol- Myers Squibb , Seattl e, WA) on ice for 75 min, followed 
by Au oroscein isothiocyanate-conjugated goa t anti - human fgG (Fe fragment-
speci fi c, Jackson lmmunoR esearch , West Grove, PA) for 60 min. Cells were 
then washed and fixed with 1% parafo rmaldehyde. Fluorescent labeled cells 
were analyzed using an Epics Pro fil e Aow cytometry analyzer (Coulter, Hialeah, 
FL), and the log Au o rescence intensity distribu tion of .I 04 cells was measured. 
Data we re analyzed with Cytologos so ftwa re program (Coulter). For steri le ce ll 
so rting, an Epics V cell sorter was used to so rt B7-1 surf.1ce- positive transfected 
Pam 212 cells fro m B7- l surfuce negati ve transfectants (methodology of Dr. 
Pete r Keng, Ca ncer Center, Uni versity of R ochester School of Medicine 
and Dentistry). 
Preparation of spleen cells and purified resting T cells Spleen cell 
suspensions (from mice 2-6 mo old) were prepared by grinding the tissue 
between the fi·osted ends of ste1ilized glass microscope slides. Single cell 
suspensio ns wen: fil te red through nylon fi lters, and red blood cell s were lyzed 
by I X AC K so lu tio n (155 mM NH 4 C L, 10 mM KH C03, 11 0 mM disodi urn 
ethylened iamine tetraacetic acid, pH 7.3) . pleen ce lls we re woshed three times, 
and viable cd ls were counted by hemacytometer w ith trypan blue exclusion. 
ForT-cell puri fica ti o n, the spleen cells were passed through an affinity column 
(Ccll ec t, 13 io tex. Edmonton, Conada) and trea ted with an ti- cl ass II antibody 
(MS/ 11 4 15.2) followed by anti -mo use lg antibody (MAR. 18.5) plus comple-
ment (I : I 0. "LOW-:T OX-M " rabbit complement, Cedar Lane Lab, Omorio. 
Canada) to remove macrophages and B cdls. The purity of these T cells was 
confirmed by in 11i1 ro fun cti o nal assays, i. e., these purified T lymphocy tes were 
unable to proli fe rate to Con A or anti -CD3 in the absence of competellt 
acccss01y ce lls (Chen er ({ /, 1995). 
Proliferation assay To test the costimubtOJy fun ctio n, freshl y ptn;fled T 
cells fi·om BALB/C mice we re used as effecto r cells and plated in 96-well 
round bottom microtitcr plates at 5 X 105 cells per we ll in 0 .2 ml T-cell 
medium (l'l.. PM I 1460 medium with se rum and supplem ents as indica ted 
previo usly plus addi tives: 0.035% 2-merc:l ptocthanol, 0.5% gent:1mycin , 0.01% 
indo methacin). y-irradi atcd parental Pam 2 12 or tmnsfec tants o r cultured 
Lange rhans cells ( I 0,000 rad) were used as the access01y cells. Con A was 
present at a concemrati on of l 0 ~g per mi. 
To exa mine pro li ferati o n of DET C, 5 X 104 per we ll y- iiTad iatcd parental 
Pam 212 or B7- '1-expressing I' am 2 12 cd ls ( I 0,000 rad) were titrated in 96-
well round-bottorn plates and DET C including A3, C3, and 7-:1 7 clones we re 
added at I X I 05 per wel l in 0.2 m.l RPM I '1460 medium supplement with 
l 0% fe tal bov ine se rum i11 the presence or absence of I ~t g; Con A per ml as 
indicated in fig ures and legends. After a 3-d incuba tion, th e cells were labeled 
with I ~tC i J3HJTdR (Arnen;ham fntermtional , Am ersham, U .K.) fo r '18 h, 
harvested, and th en counted using a scintillation counter. Proli fe rati on data 
(Figs 3, 4) depicted represent the mean (+ standard devia ti on) of triplicate 
samples. All proli fe ratio n assays were repeated three times, and we re repro-
ducible. 
Preparation of a llo reactive CTL cell clones and natural killer cells Anti -
H-2d a!Jo reacti vc T-ce ll clones we re produced as previously described (Gasco igne 
ct a/. 1984). l3rieAy, C57l3L/6 mice (H-2b) we re immunized by two intra-
peritoneal inj ectio ns o f 5 X I 07 BALD/C spleen cells (H-2d) . One wk after 
the last injecti on, the spleen cells from C57BL/6 mice we re restimulated i11 JJitm 
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Figure 3. Pam 212/B7-1 costiJnulated Con-A-induced T-cell 
proliferation. Normal BALB/ C T cells were purified by an anti- lg afrinity 
colum11 and antibody plus complement, as desc ribed previously. The T cells 
we re plated in 96-well round-bottom microtiter plates at 1 X 105 cells per 
well in 0.2 ml T-cell medium and stimulated by Con A (10 ~-tg per ml). The 
following accessory cells were y- irradiated (1 0,000 rad) : 0 , cultured Langerhans 
cells; • . Pam 212/137-1 ; ~ Pam 2 12/V. After a 48 h incubation , the T cells 
were labeled w ith 1 ~-tCi eHJTdR for 18 h and harvested . The radioactivity 
was counted by a Beckman scinti llation counter. Data represent mean of 
tripli cate samples :t SD. T cells cultured in medium a.lone or medium with 
Con A did not proliferate, as the eHlTdR. inco rpo ration w as < 1000 (data 
not shown). 
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Figure 4 . Pam 212/B7-1 costimulatcd DETC proliferation irr 11itro . 
O ne X 105 DETC ceiJ lines (A) A3, (B) C3, and (C) 7- '17 were plated in 
96-well round- bottom microtiter plates and incubated with se1ial titration of 
y- irradiatcd vecto r-transfected Pam 2 12 (opc11 sy111bols) and Pam212/ B7- l ce lls 
(closed sy11rbols) (10,000 racl) in the absence (0) or presence (0) of C on A (1 ~tg 
per ml); (0 ) DETC line 7- 17 was cocultured w ith vecto r- transfec ted Line 
I (open symbols) or B7-transfected Line ·1 (closed symbols) in the absence (6) or 
presence (0) of Con A (1 1-tg per ml). After a 48-h incubati on, the T ce lls 
we re labeled w ith I ~-tC i i3H]Tdl'l.. for 18 h and harvested . The radioactivity 
was coumed by a 13eckman scintillation co un ter. Data represent mean o f 
triplica te samples :t SD. T he pro life rati o n of DETC alo ne (no accesso1y cells) 
in response to med ium or medium with Con A is indica ted in these fi gures by 
the data point fo r zero tumor ce lls (y intercept along the .\·-ax is). 
with inadiated B.ALB/C spleen cells. Then, spleen cells were tested for specific 
anti - H-2d CTL activity and cloned by the limiting dilution method. One of 
these clones, G4, was used in this study. Natural kiiJ er cells were induced in 
nai ve BALB/CByJ mice by the intra -peritoneal injec tion of 100 J..Lg poly l:C 
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Figure 5. DETC lysis of Pam 212 was dependent on B7- 1/ CD28 
interactions. V.1ried numbers of A3 were incubated with 2000 51Cr-bbeled 
vector-transfected Pam 2 '1 2 (0) or Pam 211/.87- 1 (e ) in 96-wel \ V-bottom 
plates in the absence (A) or presence (B) of Con A (1 J..l g per 1nl) for 5 h. 
YAC-J was used as the positive control and gave 56'){, !)<sis at an effector:targe t 
ratio of 100: 1 in the absence of Con A. Varied numbers of A3 were incubated 
with 2000 51 Cr- labeled Pam 212/ 87-·J cells (•) or CTLA/ -1- lg-treated Pam 
212/ B7- l cel ls (0). which were incubated with CTLA-+lg ( I 0 J..lg per ml) fo r 
45 min on ice and washed three times with culwre medium before use in 96-
we \1 V-bottom pla tes in the absence (q or presence (D) of Con A (1 J..lg per 
nli) for 5 h. YAC-1 was used as the positive control and gave 43% lysis at an 
efiector:target (E:T) ratio of \00: I in the absence of Con A. Data represent 
mean of triplicate samples :t SD. 
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Figure 6. Pam 212/ B7- 1 cells were resistant to alloreactive CTL and 
natural killer cell-mediated lysis . Vari ed numbers of G4 CTL clone (A) or 
nJtural kiiJer cells (B) prepared JS d e~cribed in Mluerials a11d Methods were 
incubated with 2000 51Cr- labeled empty vector-transfected Pam 212 cells (0), 
Pam 212/B7- l cells (e ), EMT6/ Ro cells (.), or YA C-1 cells("-) in 96-wel\ 
V-bonom plates for 5 h. The Pam 212 and Pam 212/ il7-l were trea ted with 
lFN-y to induce class l MHC expression. Data represent mean of triplica te 
samples :': SD. E:T ratio, efiector:ta rget ratio. 
(S igma) each for 2 d befo re spleen cells were harvested. These sp\enocytes were 
treated with 1 X ACK solu tion for I Inin to remove red blood cells. T hese 
fi·es h splenocytes were used as the source of natura l killer cells. 
Cytotoxicity assay Th e cytotoxicity assay agai nst 51Cr- labe\ed target cells 
(2000 per we ll) was performed as previous ly described (Chen et a/, 1993). The 
cytotoxicity of the effec tors was determined by a 5-h assay at various dtector: 
target ratios. The percentage of spec ific lysis was ca lculated as (experi mental 
release- spontaneous release) / (maxim:Li release- spontaneous release) X 100. 
Cytotoxicity data (Figs 5, 6) depicted represem the mean (± SD) of 
triplicate sa mples . All proli feration assays were repeated three times, and were 
reproducible. 
Irr 11ir10 tmnor growth Five X "106 parental Pam 212 or Pam 212/ D7-1 
tum or cells in a volume of 50 J..ll were injected subcutaneously into the left 
Aank of nonna.l BALB/C8 yj female mice (five mice for each experimental 
group) usin g- a tuberculin sy ringe with a 26 ga uge needle. Tumor diameter was 
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Figure 7. B7-1 expression by Pam 212 does not affect irr ,,;,,o tnmor 
growth in immunocompetent BALB/ C mice nor in a thymic nude 
tnice. T he data are represented as mea n :': SD of pooled tumor grow1:h data 
fro m two groups of fi ve 111ice. Vector-transfected Pam 2·12 (opeu S)'lllho/s) 
and Pam 212/ 137- 1 (closrd symbols) were injected into th e left flank of 
iinmunocompetent BAL\3/ C mice (0, e ) or arhymic nude mice (0, • ), and 
tu tn o r d ianwter was measured ove r ri me. 
tn easured t\vice a vveek using a vern.i e.r cali per. The tmno r size \:V(Is c:dcubted 
as the square root of the product of two plana1· dimensions. Aninds were 
sacrificed when the tumor diameter reached "14- 15 111111 . The data (Fig 7) are 
depicted as th e mean (five mice per group) :': SD. 
R ESULTS 
Characterization ofB7-1-transfected Pam 212 We st3b1 y trans-
fected Pam 212 cells w ith pH-~-Apr-1 -neo empty construct (vector 
transfected, confers G4l 8 res istance) or pH-~-Apr-1-n eo empry con-
struct p lus K14-B7- 1 lcotransfected with B7-1 dri ven fi·om Kl4 
prom oter (Fig 1); G418 resistant beca use of pH-~-Apr-1-neo] . The 
transfec tallts were selec ted in G4l 8 (1 00 flg per ml) selectio n 1nedium. 
T he cell surface expression ofB7- 1 w as detected by C TLA- 4/ lg fusion 
pro tein , foll owed by Au o roscein isothi ocya nate-conjugaced second 
antibody. B7-l positive cells were sorted by two rounds of steril e cell 
so rting to enrich for stable transfectants and to select high B7-1-
expressing transfectants (Pam 212 / 137-1 ). Afte r sorting and culture, we 
re-examined B7- l antigen surface e"---p ression of Pam 2 12 / 137-1 
transfec tants by Aow cytom etty. As shown in Fig 2 , Pam 21 2/ 137- l 
transfectant (derived from cloning transfectan ts at limiting dilution) 
expressed high levels of cell surface B7- 1. N eith er th e parental Pam 
212 ce lls (Pam 212 w t) nor the vecror- transfected Pam 212 cells (Pam 
212/ V) express 137-l antigen . Treatment of Pam 212 (parental, vector 
transfec ted , o r B7 transfecrants) wi th !FN-y (100 U pe r m.l for 72 h) 
did not induce 137- 1 eJ\--pressio n (our unpublished data, nor shown). 
To determin e w hether B7- l expressed by Pam 2 12 was a fun ctional 
m olecule, w e <lSSayed the abili ty of Pam 2 12/ 137- 1 to costimu late 
pro li ferati on of purified, resting T lymp hocytes in th e presence of Con 
'A (10 fl g per ml) , and compared their costimulatory activity w ith 
profess iona l antigen-presenting cells using cultured Langerhans cells. 
As depicted in Fig 3 , bo th cultured Langerhans cells and Pam 212/ 
137-1, but not P am 21 2/ V, costimulated a stro ng T-cell proliferation 
response to Con A. T he level of costimubtOty activity of cultured 
Langerhans ceLls and Pam 212/ B7-l was compa rable . C on A alone 
indu ced minimal T-ce\1 proliferatio n; also, ')'-irradia ted accessory ce lls 
did not proliferate signifi cantl y (< 1000 cpm, data not shown). T here-
fore, P am 2 12 / 137- 1 expressed a substanti3llevel of B7- 1 and provided 
potent cos timulatory fun ctio n fo r T-cell proliferatio n. 
B7-1 cell surface expression by Pam 212 enhances DETC 
proliferation and cytolytic activity Sperbng c:t a/ reported that 
B7- "l can indu ce th e prolifera tion of T C R -y/ 8-expressin g intes tinal 
epithelial T lymph ocytes (Spe rl in g et a/, 1993). B ecause DETC have 
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been demonstrated to express CD2S, one of the physiologic ligands 
fo r 137-l (G ross et a/, 1992), we evaluated whether 137- l could provide 
costimulati on fo r DETC proliferati on, Pam 212/137- 1 was tes ted fo r 
its abili ry to stimu late three diffe rent DETC lin es. As depi cted in 
Fig 4A-C, Pam 212/137- 1, but not th e vec tor- transfected Pam 21 2, 
enhanced the proliferation of ali three DET C lin es. Interestingly, Con 
A had little effect on this enhanced costimulati ng abiliry of 137-l to 
A3 and C3 DETC lin es, but enhanced the proliferation of 7-17 in 
th e presence of 137- 1. Thus, 137-1 ca n costimulate DET C, and Con 
A may enhance this response in some n ETC lines. 
137- 1-dependent triggering of DETC proliferation is specific 
for Pam 212 To determin e whether the 137-1 expressed by other 
tumor cells would stimulate DETC proli feration similar to 137-1 
transfected Pam 212, we studied mouse lung carci noma, Line 1 (Yuhas 
et a/, 1975; Ba ber and Lord, 19S5; Yeh et a/, 1995). We compared 
empry vector transfected (control) Line 1 to 137- 1 transfected Line 1 
for i.ts abili ry to directly stimulate nETC proliferati on or costimulate 
proli fe ration to Con A. As indicated in Fig 4D, 137-1 transfected Line 
1 costimubted n ETC proliferation in response to Con A, whereas 
vector transfected Line 1 did not indu ce DETC prolife ration to Con 
A above background levels. In th e absence of Co n A, neither vecto r 
transfected Line 1 nor 137-l transfected Pam 212 induced proli fe ration 
above baseline in DETC line 7-17. These data indicate that the 
pro li fera ti on indu ced by 137-1 transfected Pam 212 was specifi c fo r 
this cell lin e, and not a properry of ail 137- 1 expressing carcinomas. 
Previous studies have reported that DET C contain perfo rin 
gra nules similar to CTL and natural killer cells (Kobata et a/, 1990; 
Mohamadzadeh et a/, 1996), thus DETC can kill some tumor targets 
(Oka moto ct a/, 1988; Kantinski et a/, 1993). Also , 137- l has been 
demonstra ted to act as an accessory molecule to ass ist the cytolytic 
process of certa in effector cells (R amarathinam ct a/, 1994; Yeh et a/, 
1995). To in vestigate whether 137-1 could fun ction as an adh esion 
molec ule in the killing abili ry of DET C to tum or cells, we studied th e 
ability of DETC to lyse vector- transfected or B7-1-transfected Pam 
212. As shown in Fig SA, B7-l expression by Pam 212 increased its 
sensi tiviry to A3 lysis relative to the parental Pam 212 (25% 115 6% at 
an effector: target ratio of 100 :1 ). Consistent with other reports 
(Okam oto et a/, 198S; Takashima ct a/, 198S; Nixon-Fulton et a/, 
1988), this enhancing effect was significantly increased in the presence 
of Con A (Fig SB). We utilized CT LA-4/ Ig fu sion protein , a 
competitive inhibitor for 137- 1 adh esion (R amarathinam et a/, 1994), 
to block the lysis of Pam 212/137-1, demonstrating that lysis was 
dependent on the tell sutface expression of B7-1 (Fig SC,D ). 137-1 
appears to be direc tly in volved in augmenting the lytic abili ry of 
DETC, proba bly by increasing th e adhesion between 137-1 on th e 
target cells and CD28+ DET C. 
137-1 does not enhance the sensitivity ofPam 212 to alloreactive 
CDS+ CTL, natural killer cell, and LAK cell lysis We also 
examined the effect of the expression of 137- 1 on the cell surface of 
Pam 212 on the killing abili ry of two effector cells, CTL (a TCR - a / 
~+ , CDS+, class l MHC- restricted CTL clone, designated G4) and 
natu ral killer cell s. We have shown that Pam 212 cells are not rej ected 
and are resistant to CTL- med.iated cytolysis in syngeneic mice (Chen 
el al, 1993) . Wh en Pam 212 cells were injected into allogeneic mice, 
the tumor was rejected and this rej ection was in part due to e n s+ 
CTL (Chen et a/, 1993) . In addition, in certa in tumor models 137-1 
has been shown to increase CTL (R ama.rathinam et al, 1994) and 
natu ra l ki ll er lyti c ability (Yeh et a/, 1995). We hypothesized that 
expression of 137-1 antigen on Pam 212 tumor cells might increase 
their sensiti viry to CTL or na tural ki ller cell- mediated cytolys is, 
especially to CD 2S+ CTL. To address this question, we generated a 
e n s+, cn2s+ anti- f-1 -2d CTL clone, designated G4. T lus CTL clone 
indu ced potent lysis of EMT6 tum.or cells (H-2d) at low effector:target 
ratios (13lieden et a/, 1991). The Pam 212 tum or cells were treated 
with !FN-y to indu ce th e expression of class I MHC (Blieden et al, 
1991). O ur A ow cytometric an alysis of IFN-y- trea ted Pam 212 (vector 
or 137-1 transfectants) indicated th at such cells expressed a high level 
of class I MH C that was equivalent to that of EMT6, a BALB/C 
mammary sarcoma. As we have previously reported (Blieden et al, 
T H E JOUR NAL O F IN VESTIGATIVE DERMATOLOGY 
1991), G4 exhibited a significant lysis of EMT6. Nonetheiess, G4 
lyzed neither th e Pam 212/137-1 nor the vec to r control when the 
target cells had been treated with IFN-y (i. e., high levels of cell surf.1ce 
class I MHC antigen expression, not shown) (Fig 6A). Wh en natural 
ki ll er cell cytolyti c acti vity was examin ed, both Pam. 212/ B7- 1 cells 
and Pam 212/V cells were resistant to natural killer cell lysis in both 
5- h (Fig 6B) and 18-h assays (data not shown). Also, 137- 1 expression 
did not afl:ect the abiliry of LAK cells to lyze either Pam 212/137-1 or 
Pam 212/vector (o ur unpublished data, not shown). Therefore, 137-1 
does not alte r the resistance of Pam 212 tumor cells to al loreactive 
CTL, natural killer cell , and LAK cell- mediated lysis. T he effect of 
137-1, if any, on these immun e cells may involve th e activation phase 
instead. of the effector phase. 
Expression of B7-1 does not affect Pam 212 tumor growth in 
immunoc01npetent or athytnic nude nuce We demonstrated 
that 137-1 was able to indu ce proliferation and enh ance lytic activiry 
of DETC in vitro in response to Pam 212 tumor cell-derived antigens. 
To exa nune whether the presence of 137- 1 could contribute to 
DETC-m.ediated protec ti on from the Pam 212 tumor growth in 1Ji11o, 
immu nocompetent BAL13/C or athymic nude mice were challenged 
with a subcutaneous inj ection of 5 X 106 empry vector-transfected 
Pam 212 or the 137-1 transfectant into the left flank; tumor grow th 
was measured over time (Fig 7). The kinetics of tumor growth for 
Pam 212/137- 1 a11d the parental Pam 21 2 were identical, indicating 
that stable expression of 137- :1 did not affect tumor cell growth , despite 
its ability to enhance its interactions with nETC i11 11itro. 
D ISCUSSI O N 
In tlus study, we describe the efl:ects of express ion of high levels of 
137-1 costimulatory molecules by Pam 212, and study its effects on 
th e interaction of tumor cells with DETC, Th cells, CTL, natural 
ki ller cells, and LAK cells. We stud ied this tum or cell line because 
w ild-rype Pam 212 is a nonimmunogeni c and tumorigenic squam ous 
cell ca rcin oma in syngeneic BALB/C hosts (Chen et a/ , 1993). We 
demonstra ted that stable cell surface expression of 137- 1 significantly 
enh anced tum.or cell interactions with DETC but did not alter the 
resistance of Pam 212 to lysis by specific CTL, natural killer cells, or 
LAK cells. 
Antigen-presenting cell - derived 137-1 costimulato ry ac tiviry is 
defin ed as a critical "second" signa] fo r T-lymphocyte activati on and 
prolifera tion for both TC1~-a/~- and T CR-y/ 8-bearing lymphocytes 
(June et a/, 1990; Linsley et a/, 1990). The first signal forT-lymphocyte 
proliferation is TCR mediated fo r antigen-specific responses (nominal 
antigen in the co ntext of class II MHC for Th cells). Previous studies 
of the CD 28 liga tion in the absence of a first signal indicated that a 
seco nd signal alone does not induce T-lymphocyte proli fe ration (June 
et a/, 1990), so it is unlikely that Pam 212/137 driven proli fe ration of 
DET C represents a response to second signal a.lone. Our observations 
that th e incubation of Pam 212/137 with TCR-a/~-bearing antigen-
specific CD4 + Th-ceU clones does not induce Th-celi proliferation 
(in the absence of specific antigens) are consistent with these observ-
ati ons (o ur unpublished data , no t shown). 
T he apparent abiliry of Pam 212/137-1 to direc tly induce th e 
proliferation of DET C may therefore represent antigen presentation 
of either a Pam 212 specific antigen or a KC-lineage specific antigen 
recognized by TCR -y/ 8-bearing DETC. Precedent for the latter 
possibiliry exists, as previous reports suggested that DETC apparently 
recognize self-antigens such as heat shock pro teins from KC in an 
MHC-unrestti cted manner (Havran et. a/, 1991; Huber et a/, 1995), 
and the ac tiva ti on of these DETC to KC requires direct cell to ceil 
contac t (Huber ct a/, 1995). ln those studies of DETC stimu lation by 
stressed KC, the role of the B7 /CD2S signaling pathway was not 
in vestiga ted. We hypoth esize that B7-l cell surface expression may 
enhance adh esion between Pam 212/137- 1 and CD 2S+ DET C, and 
costimulate T CR-mediated signaling du ring antigen presentation by 
Pam 212 to DETC of an llllidentified antigen (possibly stress proteins). 
O ur studies of 137-1-bearing Li ne 1, a mouse lung carcin oma, also 
indicate that not aU 137-1-bearing tumor cells are able to directly 
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indu ce DETC proli fe ration, inclicating that there is some specificity to 
the DET C response to Pam 212- or KC-derived antigen(s) . 
D espite its immune enhancing effects on DET C, the expression of 
B7- l by Pam 212 did not affect CTL, natural killer, and LAK cell-
mediated lysis of this tumor cell line. ln other model sys tems of B7-
1-moclified tumors, this costimulatory molecule has been noted to 
affect CTL (Ramarathinam et a/, 1994) and natural killer cells (Yeh 
et al, 1995); with both cell types playing a role in either the rej ection 
or the alteration of tumor growth kinetics . Our studies of Pam 212/ 
B7 indi ca te that the effect of this costimulatory m o.lecule on CTL and 
natural killer effector fun ction is highly dependent on the tumor cell 
that expresses the molecule. 
B7-1 expression did not alter the tumor growth kinetics in immuno-
competent or athynu c nude BALB/ C mice, as there were no statistically 
signiftcan.t differences in tumor cliameter at any tim e in either the 
immunocompetent o r the athyn-tic nude BALB/ C mice (Fig 7). This 
suggests that in spite of the presence of B7- 1 on the cell surf.Ke of 
Pam 212 tumor ce lls, in vil1o T CR -'Y/ 0-bearing T cells such as DETC 
may no t contribute suffi cient anti-tunw r imm.unity, and TCR-a/~­
beating-T cells (both CD4+ and CD S+) may be relatively important 
for the decreased ir1 vit1o tumor growth. Both vector- and B7-transfected 
Pam 21 2 grew m.ore rapidly in athyn-tic nude mice when compared 
with euthymic nuce . Because atbym.ic nude mice are know n to lack 
mature CD4 + and CDS+ T lymphocytes , this supports the concept 
that these m ature effector lymphocytes play a role in affecting Pam 
21 2 tumor growth rates . 
There are several possible reasons for DETC inabili ty to alter the 
growth of Pam 212/ B7 in 1i110 . The low frequ ency of DETC in 1i110 , 
as well as the linuted diversity of their T CR (exclusively TCR Vy3/ 
o1), may not be adequate to indu ce an anti - tumor response by 
interacti on with B7- 1-bearing Pam 212 . Similarly, the traftl ckin g of 
DETC from the epidernus to the subcutaneous site of the tumors may 
be inadequate. 
Future experiments with the adoptive transfer of DETC direc tly 
into the vici1uty of B7-bearing Pam 212 tumors will allow us to 
determine whether DETC can mediate the rej ection of this genetically 
altered tumor. 
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